Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04874207
Title Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib (RePERSO)
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Rennes University Hospital
Indications

colorectal cancer

Therapies

Regorafenib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.